Decoding Third-Party Reproduction with Dr. Marjorie Dixon

In this informative episode of Fertility in Focus, we speak with Dr. Marjorie Dixon as we delve deep into the world of third-party reproduction in Canada, covering essential topics for anyone considering or involved in gamete donation or gestational surrogacy. We start by explaining what third-party reproduction entails, including the roles and processes associated with sperm and ova donation, as well as using a gestational surrogate.

Our discussion unpacks the legal landscape governed by the Assisted Human Reproductive Act, clarifying what is permitted and prohibited under Canadian law. Dr. Dixon, a renowned expert in the field, provides an insider's view on the medical and procedural aspects involved. We discuss how egg donors are selected and assessed, including the importance of genetic testing and other health considerations. We cover the steps to obtaining legal counsel, typically facilitated by reproductive programs, and discuss the broader legal implications participants may face.

Finally, we address the existing barriers to accessing third-party reproductive services in Canada and discuss ongoing efforts to make these vital services more inclusive and accessible to all potential users. Join us for a comprehensive guide to understanding and navigating the complex, yet hopeful, world of third-party reproduction.

More About our Guest Speaker

Dr. Dixon is a graduate of McGill University’s School of Medicine. She completed her postgraduate training at the University of Toronto in Obstetrics and Gynecology and then went on to complete a 3-year sub-specialty with The American Board of Obstetrics and Gynecology at the University of Vermont to obtain an Accredited Fellowship in Reproductive Endocrinology and Infertility. Today she is a member of the Department of Obstetrics and Gynecology at Sunnybrook Health Sciences Center and is also Assistant Professor at the University of Toronto.

Dr. Dixon is the Founder, CEO and Medical Director of Anova Fertility & Reproductive Health which opened in 2016 as Canada’s newest full-service fertility and IVF centre. It is home to the first next-generation embryology laboratory in Canada and is a leader in innovation, education, and communication for high-quality humanized fertility and reproductive care.

Dr. Dixon was recognized by the Canadian Fertility and Andrology Society with the Mathias Gysler Award in 2022 for her leadership in improving reproductive care in underserved communities. She was also featured in the Globe & Mail’s Quantum Shift Class of 2019 as one of Canada’s Top Entrepreneurs. In 2018 she won the RBC Canadian Women of Influence Momentum Award and in 2017 was recognized as the YMCA Woman of Distinction. As a recognized expert in her field, Dr. Dixon is a coveted speaker at both national and international conferences. She is often asked to comment on newsworthy topics related to women’s health in the media and appears monthly on Cityline as a part of their trusted group of experts often speaking to her responsibility and championing of women’s health and reproductive well-being. 

For more information about Dr. Dixon, or about 3rd Party Reproduction in Canada, check out the Anova Fertility & Reproductive Health website at https://anovafer

First Response Canada

Afynia Laboratories, a Canadian biotechnology company, is pleased to announce the availability of EndomiR, the first validated diagnostic blood test for endometriosis. Afynia is currently offering EndomiR to Canadian fertility clinics for patients with unexplained infertility and/or symptoms suggestive of endometriosis. EndomiR shortens the diagnostic pathway by providing physicians with actionable data to inform safe and effective treatment options.